0       0

HFSA's 20th Annual Scientific Meeting


Individualizing the Assessment of Patients with HF: Steps Towards Precision Care


Description

  • Genetic Testing in DCM and HCM; Carolyn Ho, Boston, MA
  • Micro-RNA’s and Antagomirs; Palak Shah, Falls Church, VA
  • Can Plasma Metabolomics Differentiate Subgroups/Phenotypes in HF? Wilson Tang, Cleveland, OH
  • Genomics to Guide Drug Therapy – Any Hope for Real Applications? David Lanfear, Detroit, MI
  • Natriuretic Peptides and Other Biomarkers to “Guide” Therapy: Promise or Hype? James Januzzi, Boston, MA
  • Panel Discussion

Moderator(s):

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content